RFG Advisory LLC raised its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 46.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 5,760 shares of the healthcare conglomerate’s stock after acquiring an additional 1,824 shares during the period. RFG Advisory LLC’s holdings in UnitedHealth Group were worth $1,693,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Selective Wealth Management Inc. purchased a new stake in UnitedHealth Group in the third quarter worth $27,000. North Star Investment Management Corp. bought a new position in UnitedHealth Group in the third quarter worth $30,000. Delta Asset Management LLC TN lifted its position in UnitedHealth Group by 111.0% during the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 81 shares during the period. Fusion Family Wealth LLC lifted its position in UnitedHealth Group by 329.7% during the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 122 shares during the period. Finally, Massey Quick Simon & CO. LLC lifted its position in UnitedHealth Group by 212.5% during the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 119 shares during the period. 85.79% of the stock is currently owned by institutional investors and hedge funds.
In related news, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the sale, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP D Ellen Wilson sold 7,400 shares of UnitedHealth Group stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Insiders have sold 23,577 shares of company stock valued at $6,810,430 in the last three months. 0.82% of the stock is owned by insiders.
NYSE:UNH opened at $300.53 on Wednesday. The firm has a market cap of $282.77 billion, a P/E ratio of 20.97, a P/E/G ratio of 1.46 and a beta of 0.65. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.70 and a current ratio of 0.69. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $302.54. The firm has a 50-day simple moving average of $290.73 and a two-hundred day simple moving average of $256.70.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.77 by $0.13. The business had revenue of $60.90 billion during the quarter, compared to analysts’ expectations of $61.17 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the company earned $3.28 earnings per share. On average, equities research analysts predict that UnitedHealth Group Inc will post 16.47 EPS for the current year.
A number of research firms have recently weighed in on UNH. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $320.00 to $330.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $315.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, January 16th. Citigroup boosted their price objective on shares of UnitedHealth Group from $286.00 to $346.00 and gave the stock a “buy” rating in a research note on Thursday, January 16th. Wells Fargo & Co reissued an “overweight” rating and set a $335.00 price objective (up previously from $318.00) on shares of UnitedHealth Group in a research note on Wednesday, December 11th. Finally, Barclays restated a “buy” rating on shares of UnitedHealth Group in a report on Sunday. Five investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $313.50.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What are no-load funds?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.